2[2]Oligino TJ,Yao Q,Ghivizzani SC,et al.Vector systems rof gene transrer to transfer to joints. Clin Orthop, 379(Suppl):S 17-S30.
3[3]Robbins PD,Ghivizzani SC.Viral vectors for gene therapy. Pharmacol THer, 1998,80:35-47.
4[4]Younger FM,Chapman MW.Morbidity at bone graft donof sites.J Orthop Trauma, 1989,3:192-195.
5[5]Hollinger JO,Winn S,Bonadio J.Options for tissue engineeing to address challenges of the aging skeleton. Tissue Eng,2000,6:341-350.
6[6]Lieberman JR,Daluiski A,Stevenson S,et al.The effect of regional gene therapy with bone morphogenetic protein-2 producing bone-marrow cells of repair of segmental remoral derects in rats.J Bone Joint Surg, 1999,81A:905-917.
7[7]Breitbart AS,Grande da,Mason JM,et al .Gene-entanced tissue engineeing :Applications for bone healing using cultured periosteal cells trantduced retrovirally with BMP-7 gene. Ann Plast Surg, 1999,42:488-495.
8[8]Baltzer AW,Lattermann C,Whalen JD,Ghivizzani S,et al. Ptential role of direct adenoviral gene transfer in enhancing fracture repaif. Clin Orthop,2000,379(Suppl):S 120-S 125.
9[9]Fang J,Zhu YY,Smiley E, et al.Stimulation of new bone by direct transfer osteogenic plasmid genes. Pro Nah Acad Sci,1996,93:5753-5758.
10[10]Bonadio J,Smiley E,Patil P, et al. Localized,direct plasmid gene delivery in vivo:Prolonged therapy resuots in reproducible tissue regeneration. Nat Med, 1999,5:753-759.
